---
author: Di Shao
categories:
- talks
date: "2023-05-06"
draft: false
excerpt: 包括四个部分的内容：1.PARPi抑制剂使用场景卵巢癌维持治疗；2.从STUDY19到SOLO2,SOLO1得到PARPi标志物的启示；3.HRD概念和检测方法以及在PRIMA和PAOLA1中的预测效果
featured: true
layout: single
show_post_time: false
subtitle: 
title: 从BRCA，HRR到HRD，卵巢癌PARPi维持治疗靶点探索
---

以下Slides来源于公开会议，仅用于个人学习

<div style="position: relative; width: 100%; height: 0; padding-top: 56.2500%;
 padding-bottom: 0; box-shadow: 0 2px 8px 0 rgba(63,69,81,0.16); margin-top: 1.6em; margin-bottom: 0.9em; overflow: hidden;
 border-radius: 8px; will-change: transform;">
  <iframe loading="lazy" style="position: absolute; width: 100%; height: 100%; top: 0; left: 0; border: none; padding: 0;margin: 0;"
    src="https:&#x2F;&#x2F;www.canva.cn&#x2F;design&#x2F;DAFimPH40s8&#x2F;watch?embed" allowfullscreen="allowfullscreen" allow="fullscreen">
  </iframe>
</div>

